Research and Markets has announced the addition of the "Urolithiasis Management Devices Market Analysis By Treatment Type, Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatments, By End Use And Segment Forecasts To 2024" report to their offering.

The global urolithiasis management devices market was valued at USD 1.27 billion in 2015 and is expected to be valued at USD 1.93 billion by 2024.

The alarming growth in the incidence rate of urinary stones, over the years, is responsible for the advancements in the treatment options. European Association of Urology states that it is one of the most common lifestyle disorders with a 10% prevalence rate and requires a systematic treatment approach.

Furthermore, percutaneous nephrolithotomy is a surgical approach deployed to eliminate larger stones where extracorporeal or intracorporeal lithotripsies prove to be ineffective and typically require a week's hospitalization.

Ambulatory surgical centers are gaining popularity over traditional hospital and clinic settings due to the time and cost saving benefits. As a result, this end-use segment is expected to record a lucrative growth rate during the forecast period. Introduction of novel surgical technologies, such as endoscopy and micro accessories including guidewires, scalpels, and baskets, to effectively expel stones from the urinary system in a short time has enhanced the overall acceptability of minimally invasive surgeries.

Key Topics Covered:

1 Methodology & Scope

2 Executive Summary

3 Market Summary

4 Market Variables, Trends& Scope

5 Market Categorization 1: Treatment Type Estimates & Trend Analysis

6 Market Categorization 2: End-Use Estimates & Trend Analysis

7 Market Categorization 3: Regional Estimates & Trend Analysis, by Treatment Type, and End-Use

8 Competitive Landscape

  • Allengers Medical Systems Ltd.
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cook Medical
  • ConMed Corporation
  • DirexGroup
  • Dornier MedTech GmbH
  • Guangzhou Potent Optotronic Technology Co., Ltd.
  • HealthTronics, Inc.
  • Karl Storz GmbH & Co. KG
  • Lumenis
  • Olympus Corporation
  • Richard Wolf
  • Siemens Healthcare

For more information about this report visit http://www.researchandmarkets.com/research/fvbvg6/urolithiasis